Literature DB >> 11532833

COX 2 inhibitors may increase risk of heart attack.

S Gottlieb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532833      PMCID: PMC1121075     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  Cancer cell signaling pathways targeted by spice-derived nutraceuticals.

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Bharat B Aggarwal
Journal:  Nutr Cancer       Date:  2011-12-09       Impact factor: 2.900

2.  Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses.

Authors:  Rongqin Ren; Peter C Charles; Chunlian Zhang; Yaxu Wu; Hong Wang; Cam Patterson
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

3.  The effects of cyclooxygenase and nitric oxide synthase inhibition on oxidative stress in isolated rat heart.

Authors:  Nevena Barudzic; Drenka Turjacanin-Pantelic; Vladimir Zivkovic; Dragica Selakovic; Ivan Srejovic; Jovana Joksimovic; Jovana Jakovljevic; Dragan M Djuric; Vladimir Lj Jakovljevic
Journal:  Mol Cell Biochem       Date:  2013-06-09       Impact factor: 3.396

4.  Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine/chemokine production in human whole blood.

Authors:  Daniela Ribeiro; Marisa Freitas; Sara M Tomé; Artur M S Silva; Stefan Laufer; José L F C Lima; Eduarda Fernandes
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

5.  Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids.

Authors:  Hyoung-Woo Bai; Bao Ting Zhu
Journal:  J Lipid Res       Date:  2008-07-26       Impact factor: 5.922

6.  Myricetin and quercetin are naturally occurring co-substrates of cyclooxygenases in vivo.

Authors:  Hyoung-Woo Bai; Bao Ting Zhu
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-11-07       Impact factor: 4.006

7.  The effects of cyclooxygenase and nitric oxide synthase inhibition on cardiodynamic parameters and coronary flow in isolated rat hearts.

Authors:  Vladimir Zivkovic; Dragan Djuric; Drenka Turjacanin-Pantelic; Zeljko Marinkovic; Djordje Stefanovic; Ivan Srejovic; Vladimir Jakovljevic
Journal:  Exp Clin Cardiol       Date:  2013

8.  WIN-34B May Have Analgesic and Anti-Inflammatory Effects by Reducing the Production of Pro-Inflammatory Mediators in Cells via Inhibition of IκB Signaling Pathways.

Authors:  Kyoung Soo Kim; Hyun Mi Choi; Hyung-In Yang; Myung Chul Yoo
Journal:  Biomol Ther (Seoul)       Date:  2012-01       Impact factor: 4.634

9.  Selective cyclooxygenase-2 inhibition protects against myocardial damage in experimental acute ischemia.

Authors:  Alberto Carnieto; Paulo Magno Martins Dourado; Protásio Lemos da Luz; Antonio Carlos Palandri Chagas
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  The adverse effect of selective cyclooxygenase-2 inhibitor on random skin flap survival in rats.

Authors:  Haiyong Ren; Dingsheng Lin; Zhenyu Mou; Pu Dong
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.